GlassScriptPhysician profile
Paul Henry Blom
NPI 1184601908
$1,543.15
in general payments reported to CMS, 2019-2025
11 companies · $783 in 2025
The $783 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $384 · 2021: $123 · 2022: $3.49 · 2023: $188 · 2024: $61.54 · 2025: $783.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,033.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,032.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $403.04 | 2025 | |
| Penumbra, INC. | $365.30 | 2021-2025 | Penumbra System, Indigo System |
| Endologix LLC | $339.33 | 2020 | |
| Shockwave Medical, INC | $207.63 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Cook Medical LLC | $54.22 | 2021 | |
| Boston Scientific Corporation | $45.10 | 2025 | Obsidio |
| Bard Peripheral Vascular, INC. | $37.37 | 2020-2021 | |
| Microvention, INC. | $29.61 | 2025 | Stent |
| Cardiovascular Systems INC. | $24.01 | 2020 | |
| Stryker Corporation | $23.28 | 2024 | Target |
| Thrombolex, INC. | $14.26 | 2025 | Bashir Endovascular Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Blom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.